Quiets overexcitation
Glutamate/NMDA↓
Also searched as Glutamate/NMDA.
You want it balanced: enough for antioxidant defense, restrained against excitotoxic excess.
In depth
The cystine–glutamate exchange that supplies antioxidant building blocks while tuning excitatory neurotransmission.
What drives it
Antioxidant defense increases it.
xCT/system xc- review — Nrf2 binds antioxidant-response elements in the SLC7A11 promoter to induce xCT, the cystine/glutamate antiporter that imports cystine (for glutathione) while exporting glutamate. PMC5603608
Lowers cortisol increases it.
acute: glucocorticoids released during initial stress cause long-lasting potentiation of ampa and nmda receptor currents in pyramidal neurons, increasing surface expression of those receptors and improving working memory — the stress response sharpening the machinery it needs. Excess OR prolonged: the same combination exacerbates excitotoxic insults by increasing intracellular calcium, while high glucocorticoid levels deplete available energy and inhibit cellular growth. The authors conclude that over time it may become beneficial to limit the signals associated with acute stress in these regions — the same signal that helps briefly harms when held. doi 10.1186/s12974-021-02309-6
Gut barrier reduces it.
NMR of germ-free versus specific-pathogen-free mouse brain found brain acetate significantly reduced in germ-free animals (p=0.012) while glutamate (p=0.0013), glutamine (p=0.0006) and N-acetyl aspartate (p=0.0046) were increased — so the presence of a microbiome lowers brain glutamate, which is why this edge is drawn inhibitory. And it tracks a functional readout: cFOS mRNA was significantly decreased in the prefrontal cortex of germ-free mice (p=0.044) and correlated with the abundance of the altered metabolites including glutamate and glutamine. germ-free animals are a causal tool but an extreme one — no human has this phenotype. The finding establishes that the microbiome sets brain glutamate tone, not the size of that effect in a colonized human. doi 10.3389/fnmol.2023.1155620
The Two-Faced Peptide reduces it.
Dynorphin acting on presynaptic KORs inhibits glutamate release from afferent inputs to the prefrontal cortex, but selectively: with channelrhodopsin in each source region, dynorphin inhibited inputs from the paraventricular thalamus, basolateral amygdala and contralateral cortex, but not from the ventral hippocampus. One peptide, four inputs, three silenced. Presynaptic proven by exclusion: dynorphin failed to modify currents evoked by glutamate UNCAGING — bypassing the terminal abolishes the effect, so it acts on release, not on the receiving neuron. The block was reversed by norBNI without leaving plasticity behind. And the anxiety link is causal: KOR activation inhibits glutamate release from BLA inputs to the BNST and OCCLUDES the anxiolytic phenotype produced by optogenetic activation of BLA-BNST projections, while deletion of KORs from amygdala neurons produces an anxiolytic phenotype. doi 10.1038/s41380-023-02226-5
Brain inflammation increases it.
activated microglia secrete glutamate through system xC-, the cystine/glutamate antiporter, in a 1:1 exchange of extracellular cystine for intracellular glutamate. And the cell is not attacking — it is feeding itself: inside the cell that cystine is reduced to cysteine, the limiting reagent for glutathione biosynthesis. The in-vivo caveat is the most important part and the authors state it themselves: the view that microglia cause excitotoxicity has evolved mostly from in-vitro studies. In vivo, low-dose LPS microinjected into spinal gray matter activated CNS macrophages without causing overt NEUROPATHOLOGY — neurotoxic inflammation occurred only when LPS and cystine were co-injected. Activation alone is not sufficient; it takes activation plus substrate. Two hits, not one. And the relationship is a loop: activated microglia secrete glutamate but ARE also activated by exogenous glutamate, expressing both metabotropic and ionotropic glutamate receptors, so released glutamate can act in an AUTOCRINE fashion on neighboring microglia. Human: activated human monocytes release glutamate through xc- with xCT upregulated on activation, and xCT expression is raised in multiple sclerosis in both CNS and peripheral blood cells. doi 10.1186/s12974-023-02972-x · PMC3268895
Calm reduces it.
Excitation-inhibition balance is the most basic organising principle in the brain. GABA is the principal inhibitory transmitter and glutamate the principal excitatory one; GABAergic interneurons restrain glutamatergic output, and the ratio between them is what anxiolytics, anticonvulsants, anaesthetics and excitotoxicity are all about. The sign is drawn inhibitory on GABA restraining glutamatergic transmission, which is the standard direction — but the relationship is reciprocal and the map draws one arrow. The reverse arm (glutamate driving GABAergic interneuron activity as feedback inhibition) is real and is not drawn. That asymmetry is stated rather than hidden, as it is for GH and IGF-1 and for weight and leptin. PMC3677985
What it drives
It increases Calm under stress.
Glutamate is the excitatory counterweight to GABA inhibition, and a full review is devoted to glutamate systems in dsm-5 anxiety disorders. Anatomically the case is explicit: the basolateral amygdala activates the central amygdala directly through an excitatory glutamatergic pathway, as well as through a relay of inhibitory GABAergic interneurons — the two transmitters are wired into the same circuit in opposition. Why it matters clinically: serotonin and GABA drugs fail a significant proportion of patients, which is precisely why glutamate-modulating agents are being pursued as alternatives — the unmet need defines the gap. PMC7710541
It increases Mood (serotonin).
The mechanism is a glutamate receptor: alpha-1-mediated excitatory transmission is carried by the ionotropic glutamate receptor HOMOLOG cation channel delta glutamate receptor 1 (GluD1), which is constitutively active under basal conditions carrying tonic inward current, and alpha-1 activation augments that tonic current. And deleting it causes anxiety: loss of dorsal raphe GluD1R channels produces an anxiogenic phenotype — a direct behavioral readout, not an inferred one. GluD1 is responsible for the alpha-1-dependent persistent pacemaker-type firing of raphe neurons. tonic noradrenergic input is stated to be required for 5-HT neurons to fire and release serotonin, so this channel sits on the critical path of the whole serotonergic output. PMC7180053
It reduces Mood.
It broke the monoamine monopoly. Elevated levels of glutamate have been found in the blood, cerebrospinal fluid and brains of patients with depression, alongside NMDA receptor subunit disturbances. The inhibition of NMDA receptor function has antidepressant effects. Ketamine is mechanistically novel, effective and rapidly acting — hours rather than the weeks every monoamine drug requires. That time course is itself the argument: whatever ketamine does, it is not waiting for monoamine receptor adaptation. The glutamate story and the neurotrophin story are one pathway, not two competing ones. The sign is subtle: drawn inhibitory because elevated tonic glutamate and NMDA overactivity associate with depression — yet the antidepressant works by causing a burst at AMPA. Tonic NMDA and phasic AMPA point opposite ways. Anything sold as raising or lowering glutamate is ignoring which receptor and which timescale. doi 10.1002/mco2.156 · PMC12124046
It reduces Sleep.
Glutamate is an important mediator in waking mechanisms and has a widespread influence on the sleep-wake regulatory system, with glutamate levels increasing during wakefulness. And it is the substrate for the other side of the switch: GABA is synthesized from glutamate by glutamic acid decarboxylase, so the excitatory and inhibitory arms of sleep regulation share a precursor — the GABA → Sleep link is already drawn here. Rising with wakefulness is an observation, not a mechanism: no retrieved study manipulated glutamate and measured sleep. Weak accordingly. PMC7851648
It increases Calm.
10.1523/JNEUROSCI.2630-18.2019 — It is now. Glutamatergic input onto GABAergic interneurons is feedback and FEEDFORWARD inhibition - the basic microcircuit motif of cortex and hippocampus. Excitation recruits its own restraint; that is what makes a circuit rather than a runaway. Same fifteen-source co-citation base as its partner arm, which is not a measured step, and both arms carry that limit. doi 10.1523/JNEUROSCI.2630-18.2019
It reduces Neurovascular calm.
Cortical spreading depression is the mechanism and it is physically described: a slow spreading wave of depolarization in glial and neuronal cells, a slow direct current potential shift due to high extracellular potassium ions with high intracellular sodium and calcium ions. At the cellular level CSD is characterized by ionic changes and excitotoxicity. One of its downstream events is trigeminovascular system activation, which facilitates the release of nitric oxide to cause vasodilation - the aura and the headache are the same event at two depths. PMID 36361791 · PMC10933035
It reduces Hearing.
NIHL is not merely caused by physical damage, it is also metabolic in nature: acoustic over-stimulation can promote the excessive release of the neurotransmitter glutamate at the inner hair cell synapse (excitotoxicity), a rapid increase in reactive oxygen species, and release of free radicals in the cochlea, leading to apoptosis and hair cell OR neuronal death. This is the same excitotoxicity the ECSTATIC blend is built around, arriving in the cochlea. doi 10.1016/j.heares.2015.01.002 · PMID 36457967
It increases Calm pain signaling.
The defining feature is that the pain is real and the tissue is not damaged: central sensitization manifests as hyperalgesia, allodynia, expanded receptive fields, and impaired endogenous pain inhibition, and in osteoarthritis the same phenomenon does not correlate with radiographic findings - severe pain may persist despite stable joint structure. The mechanism is a balance failure in both directions at once: in the dorsal horn there is excessive release of glutamate, ATP, and substance P, leading to activation of NMDA receptors - while at the same time descending inhibitory mechanisms, notably those mediated by GABA, ARE weakened. Too much excitation and too little inhibition. And mast cells carry a specific hypothesis: thalamic mast cells releasing histamine, IL-1-beta, IL-6, TNF, CGRP and substance P, either stimulating thalamic nociceptive neurons directly or via microglia. Stated by the authors as a hypothesis, not an established mechanism. The reviewers ARE blunt about the state of knowledge: the pathophysiology and etiopathogenesis remain largely unknown, and there is NO definitive pathogenesis except for altered central pain pathways. doi 10.3390/biomedicines12071543 · PMC6687840
It reduces Alcohol recovery.
10.3389/fnins.2015.00144 — Drawn from reviews of neighboring outcomes rather than from studies of this outcome itself, which is weaker evidence, and the map marks it so. doi 10.3389/fnins.2015.00144
It increases Cortical spreading wave.
CSD propagates through massive glutamate release and NMDA-receptor-dependent depolarization of adjacent cortex. doi 10.1152/physrev.00027.2020 · PMC7786797
It increases Fear extinction.
While NMDA receptor antagonists impair extinction, the receptor partial agonist D-cycloserine facilitates it, acting at the glycine modulatory site on the NR1 subunit to increase calcium influx. doi 10.1111/j.1601-183X.2012.00801.x · PMC2787650
It increases Neuronal overexcitation.
Glutamate is the brain's principal excitatory messenger, and it becomes a neurotoxin the moment clearance fails: the resulting rise in extracellular glutamate drives a massive influx of sodium and calcium through NMDA receptors. The transporter modeled here exports glutamate while importing cystine for glutathione, so raising it protects the cell against oxidation and raises the excitotoxic load at the synapse - the same molecule reads opposite by compartment. doi 10.1186/s40035-021-00278-7 · PMC8788129
It reduces Plasticity switch.
Calcium entering through extrasynaptic NMDA receptors - reached by a glutamate flood rather than by synaptic release - activates a general and dominant CREB shut-off pathway that blocks induction of BDNF expression, while calcium through synaptic receptors switches CREB on as strongly as an L-type calcium channel does. The same ion, the same receptor family, opposite verdicts decided by location. doi 10.1038/nn835 · PMID 11953750 · PMC5339681
It increases Learning & memory.
10.1038/s42003-024-06586-8 — The experience-driven change in synaptic strength, universally known as long-term potentiation (LTP), is initiated during memory encoding and requires functional and structural modifications, such as the…. doi 10.1038/s42003-024-06586-8 · PMC12898322
Blends that modulate it
Each blend page names this pathway and carries the study behind its claim.
See it on the map
Open the causal map to follow this pathway upstream and downstream, arrow by arrow, each with its study.